Rein Therapeutics Ownership | Who Owns Rein Therapeutics?


OverviewFinancialsChart

Rein Therapeutics Ownership Summary


Rein Therapeutics is owned by 44.79% institutional investors, 1.53% insiders, and 53.69% retail investors. Voss capital is the largest institutional shareholder, holding 17.25% of RNTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.67% of its assets in Rein Therapeutics shares.

RNTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRein Therapeutics44.79%1.53%53.69%
SectorHealthcare Stocks 35.58%11.87%52.55%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Voss capital4.39M17.25%$5.70M
Bios capital management, lp1.98M7.79%$2.58M
Vanguard group1.17M4.42%$1.35M
University of texas/texas am investment managment511.61K2.01%$665.09K
Cable car capital420.00K1.65%$546.00K
Prosight management, lp411.60K1.62%$535.08K
Sigma planning348.68K1.37%$453.28K
Geode capital management344.69K1.35%$448.19K
Texas capital bank wealth management services273.63K1.08%$355.71K
Gagnon securities239.52K0.94%$311.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp1.98M4.87%$2.58M
Kck22.34K0.34%$52.05K
Voss capital4.39M0.30%$5.70M
Cable car capital420.00K0.19%$546.00K
Abs direct equity fund125.00K0.12%$162.50K
Palogic value management180.00K0.10%$234.00K
University of texas/texas am investment managment511.61K0.10%$665.09K
Prosight management, lp411.60K0.09%$535.08K
Gagnon securities239.52K0.07%$311.38K
Texas capital bank wealth management services273.63K0.02%$355.71K

Top Buyers

HolderShares% AssetsChange
Bios capital management, lp1.98M4.87%291.62K
Palogic value management180.00K0.10%180.00K
Vanguard fiduciary trust154.51K0.00%154.51K
Voss capital4.39M0.30%144.39K
Sigma planning348.68K0.01%101.40K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---120.08K
Jane street group---61.96K
Susquehanna group, llp---58.99K
Two sigma investments, lp---41.71K
Prosight management, lp411.60K0.09%-31.00K

New Positions

HolderShares% AssetsChangeValue
Palogic value management180.00K0.10%180.00K$234.00K
Vanguard fiduciary trust154.51K0.00%154.51K$200.87K
Sanders morris harris20.00K0.00%20.00K$26.00K
Steel peak wealth management13.00K0.00%13.00K$16.90K
Vanguard global advisers12.77K-12.77K$16.61K

Sold Out

HolderChange
Citigroup-1.00
Game plan financial advisors-25.00
Jpmorgan chase-32.00
Advisor group-70.00
Hexagon capital partners-213.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202645-2.17%11,396,5245.53%442.67%25-3.85%4-20.00%
Dec 31, 202522-43.59%2,725,534-67.89%100.84%11-15.38%2-75.00%
Sep 30, 202519-45.71%3,856,409-42.07%152.10%5-64.29%3-40.00%
Jun 30, 202535-5.41%6,657,20910.63%303,7610.04%14-62.16%5-
Mar 31, 202536-5,995,080-27,636-36---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv734.42K2.67%-
Vanguard Institutional Extnd Mkt Idx Tr264.10K0.96%-
Fidelity Extended Market Index153.96K0.56%40.54K
Fidelity Nasdaq Composite ETF75.07K0.27%-
iShares Micro-Cap ETF65.40K0.24%-
Northern Trust Extended Eq Market Idx35.84K0.13%14.71K
NT Ext Equity Mkt Index Fund - Lending35.84K0.13%-
Fidelity Total Market Index35.24K0.13%-
Spartan Extended Market Index Pool F33.65K0.12%17.53K
Fidelity Series Total Market Index29.98K0.11%2.12K

Recent Insider Transactions


DateNameRoleActivityValue
May 27, 2026VON RICKENBACH JOSEF H-Buy$4.82K
May 21, 2026VON RICKENBACH JOSEF H-Buy$3.56K
May 22, 2026VON RICKENBACH JOSEF H-Buy$16.71K
May 26, 2026VON RICKENBACH JOSEF H-Buy$24.47K
Apr 30, 2026WINDSOR JAMES BRIAN See RemarksBuy$25.00K

Insider Transactions Trends


DateBuySell
2026 Q25-
2025 Q45-
2025 Q3--

RNTX Ownership FAQ


Who owns the most shares of Rein Therapeutics?

Rein Therapeutics’s largest shareholders are Voss capital (4.39M shares, 17.25%), Bios capital management, lp (1.98M shares, 7.79%), and Vanguard group (1.17M shares, 4.42%). Together, they hold 29.46% of Rein Therapeutics’s total shares outstanding.

Does Blackrock own Rein Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rein Therapeutics.

Who is Rein Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Rein Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.87% of its assets in 1.98M Rein Therapeutics shares, valued at 2.58M$.

Who is the top mutual fund holder of Rein Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rein Therapeutics shares, with 2.67% of its total shares outstanding invested in 734.42K Rein Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools